Literature DB >> 12680714

Proliferation of intracellular structure corresponding to reduced affinity of fluconazole for cytochrome P-450 in two low-susceptibility strains of Candida albicans isolated from a Japanese AIDS patient.

Kazunori Maebashi1, Michinari Kudoh, Yayoi Nishiyama, Koichi Makimura, Yasuki Kamai, Katsuhisa Uchida, Hideyo Yamaguchi.   

Abstract

Three Candida albicans isolates, TIMM 3164, 3165 and 3166 with reduced fluconazole susceptibility, were isolated from two Japanese AIDS patients. We earlier reported that a reduced intracellular accumulation of fluconazole in these isolates played an important role in the resistance mechanism of fluconazole, but we did not exclude the involvement of other factors. We here examined characteristics related to cytochrome P-450 (CYP), especially sterol 14alpha-demethylase encoded by the ERG11 gene which is the target molecule for fluconazole. In TIMM 3164 and 3165, the ergosterol synthesis by cell-free extracts was somewhat less susceptible to fluconazole, due to a decrease in fluconazole affinity for CYP. The nucleotide substitutions in the ERG11 gene were identified to result in three amino acid changes of K143R, E266D and V488I in TIMM 3164, and of E266D, V404L and V488I in TIMM 3165. These amino acid substitutions might contribute to the decreased affinity for CYP in both isolates. However, a single amino acid change, E266D, observed in TIMM 3166 was unrelated to the decreased affinity for CYP. The most prominent finding on the ultrastructure of TIMM 3164 and 3165 was the development of mesh membrane structures of the endoplasmic reticula, which is a location related to sterol synthesis. This phenomenon was not observed in the cells of TIMM 3166 or the susceptible control strains of ATCC 90028 and 10231. In addition to the reduced intracellular accumulation, the decreased affinity of fluconazole for CYP in TIMM 3164 and 3165 is assumed to be associated with the fluconazole-resistance phenotype.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12680714     DOI: 10.1111/j.1348-0421.2003.tb02794.x

Source DB:  PubMed          Journal:  Microbiol Immunol        ISSN: 0385-5600            Impact factor:   1.955


  3 in total

1.  Detection of ERG11 point mutations in Iranian fluconazole-resistant Candida albicans isolates.

Authors:  Ali Sardari; Hossein Zarrinfar; Rasoul Mohammadi
Journal:  Curr Med Mycol       Date:  2019-03

2.  Antifungal activity of geldanamycin alone or in combination with fluconazole against Candida species.

Authors:  Jinqing Zhang; Wei Liu; Jingwen Tan; Yi Sun; Zhe Wan; Ruoyu Li
Journal:  Mycopathologia       Date:  2013-01-23       Impact factor: 2.574

3.  Principles of a New Protocol for Prediction of Azole Resistance in Candida albicans Infections on the Basis of ERG11 Polymorphisms.

Authors:  Monika Caban; Dominik Strapagiel; Jarosław Dziadek; Małgorzata Korycka-Machała; Agnieszka Grzelak
Journal:  Curr Microbiol       Date:  2016-04-23       Impact factor: 2.188

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.